Q&A Session for RPP-24-07-mAbs for “Manufacturing Optimization for Filovirus Monoclonal Antibodies”

On July 12, 2025, the BioMaP-Consortium hosted a live Q&A Session with the government to address questions from potential respondents in support of the RPP-24-07-mAbs for “Manufacturing Optimization for Filovirus Monoclonal Antibodies”. Questions and answers addressed during the live session were included in the solicitation documents for RPP-24-07-mAbs.